You are viewing the site in preview mode
Skip to main content
| | N (%) | Mean (Standard Deviation) |
|---|
| Age Group |
| < 25 yrs | 194 (40%) | 29.7 yrs. (9.4 yrs) |
| 25–29 yrs | 124 (25%) | |
| 30–34 yrs | 78 (16%) | |
| 35–39 yrs | 34 (7%) | |
| 40–44 yrs | 20 (4%) | |
| 45–49 yrs | 13 (3%) | |
| ≥ 50 yrs | 25 (5%) | |
| Ethnic Group |
| Eskimo | 238 (49%) | |
| Indian | 149 (31%) | |
| Aleut | 73 (15%) | |
| Mixed | 17 (3%) | |
| Non-Native | 9 (2%) | |
| Non-specific Native | 2 (0.4%) | |
| Tobacco use, ever | 246/484 (51%) | |
| Current tobacco user | 225/471 (48%) | |
| Number of HPV vaccine doses |
| 0 | 440 (90%) | |
| 1 | 18 (3.7%) | |
| 2 | 9 (1.8%) | |
| 3 | 20 (4.1%) | |
| 4 | 1 (0.2%) | |
| Ectocervical biopsy done | 438 (90%) | |
| Endocervical curettage done | 402 (82%) | |
| Loop Electrosurgical Excision Procedure done | 42 (8.6%) | |
| Cytology Referral Diagnosis |
| Atypical Squamous Cells of Undetermined Significance | 231 (47%) | |
| Low-grade Squamous Intraepithelial Lesion | 162 (33%) | |
| High-grade Squamous Intraepithelial Lesion | 46 (9%) | |
| Atypical Squamous Cells cannot exclude High-Grade Squamous Intraepithelial cells | 25 (5%) | |
| Unknown | 24 (5%) | |
| Final Pathology Diagnosis |
| CIN* 3 | 22 (5%) | |
| CIN 2 | 45 (9%) | |
| CIN 1 | 184 (38%) | |
| Metaplasia/Inflammation | 135 (28%) | |
| Other** | 46 (9%) | |
| Insufficient/No biopsy | 55 (11%) | |
| Number of HPV types in HPV positive specimens |
| 1 | 126 (28%) | 2.6 (SD = 1.57) |
| 2 | 126 (28%) | Median = 2 |
| 3 | 94 (21%) | |
| 4 | 55 (12%) | |
| 5 | 31 (7%) | |
| 6+ | 26 (6%) | |
| Number of 9-valent HPV vaccine types present |
| 0 | 184 (38%) | 0.88 (SD = 0.87) |
| 1 | 205 (42%) | |
| 2 | 76 (16%) | |
| 3 | 19 (4%) | |
| 4 | 4 (0.8%) | |
- *CIN Cervical intraepithelial neoplasia
- ** Other = Atrophy, Atypia, Negative
